Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival

Journal of Surgical Research

Volumn 164, Issue 1, 2010, Pages

  Wang, Jiansheng ^a   Zhang, Mingxin ^a   Zhang, Lingmin ^a   Cai, Hui ^a   Zhou, Suna ^a   Zhang, Jia ^a   Wang, Yang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

gallbladder cancer; heme oxygenase 1 (HO 1); multidrug resistance related protein 3 (MRP3); NF E2 related factor 2 (Nrf2)

Indexed keywords

HEME OXYGENASE 1; ISONIAZID; MULTIDRUG RESISTANCE PROTEIN 3; TRANSCRIPTION FACTOR NRF2;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER NEOPLASMS; HEME OXYGENASE-1; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NF-E2-RELATED FACTOR 2; P-GLYCOPROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 77958113395     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.05.058     Document Type: Article

References (24)

1. G. Randi, S. Franceschi, and C. La Vecchia Gallbladder cancer worldwide: Geographical distribution and risk factors Int J Cancer 118 2006 1591
2. G. Randi, M. Malvezzi, and F. Levi Epidemiology of biliary tract cancers: An update Ann Oncol 20 2009 146
3. S. Misra, A. Chaturvedi, and N.C. Misra Carcinoma of the gallbladder Lancet Oncol 4 2003 167
4. S.M. Hong, M.J. Kim, and D.Y. Pi Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients Cancer 104 2005 802
5. R.D. Goldin, and J.C. Roa Gallbladder cancer: A morphological and molecular update Histopathology 55 2009 218
6. T.W. Kensler, N. Wakabayashi, and S. Biswal Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu Rev Pharmacol Toxicol 47 2007 89
7. A. Lau, N.F. Villeneuve, and Z. Sun Dual roles of Nrf2 in cancer Pharmacol Res 58 2008 262
8. T. Shibata, A. Kokubu, and M. Gotoh Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer Gastroenterology 135 2008 1358
9. S. Homma, Y. Ishii, and Y. Morishima Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer Clin Cancer Res 15 2009 3423
10. S.K. Kim, J.W. Yang, and M.R. Kim Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells Free Radic Biol Med 45 2008 537
11. A. Singh, V. Misra, and R.K. Thimmulappa Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer PLoS Med 3 2006 e420
12. S. Rau, F. Autschbach, and H.D. Riedel Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas Eur J Clin Invest 38 2008 134
13. J.E. Nevin, T.J. Moran, and S. Kay Carcinoma of the gallbladder: Staging, treatment, and prognosis Cancer 37 1976 141
14. Q.F. Pang, Y. Ji, and L.G. Bermúdez-Humarán Protective effects of a heme oxygenase-1-secreting Lactococcus lactis on mucosal injury induced by hemorrhagic shock in rats J Surg Res 153 2009 39
15. P. Moi, K. Chan, and I. Asunis Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region Proc Natl Acad Sci USA 91 1994 9926
16. D.D. Zhang Mechanistic studies of the Nrf2-Keap1 signaling pathway Drug Metab Rev 38 2006 769
17. B. Padmanabhan, K.I. Tong, and T. Ohta Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer Mol Cell 21 2006 689
18. P. Nioi, and T. Nguyen A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity Biochem Biophys Res Commun 362 2007 816
19. A. Jozkowicz, H. Was, and J. Dulak Heme oxygenase-1 in tumors: Is it a false friend? Antioxid Redox Signal 9 2007 2099
20. L.M. Aleksunes, A.L. Slitt, and J.M. Maher Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2 Toxicol Appl Pharmacol 226 2008 74
21. Z. Benderra, A.M. Faussat, and L. Sayada MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia Clin Cancer Res 11 2005 7764
22. S.L. Plasschaert, E.S. de Bont, and M. Boezen Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia Clin Cancer Res 11 2005 8661
23. M.H. Tsuji, T. Yanagawa, and S. Iwasa Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis Cancer Lett 138 1999 53
24. J.H. Kim, P.N. Bogner, and N. Ramnath Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer Clin Cancer Res 13 2007 3875